Loading people...
Vincent Brichard is a venture capitalist specializing in life sciences who currently serves as a Venture Partner at EQT Life Sciences. He initially entered the venture capital sector by joining LSP in 2016, a firm that subsequently joined forces with EQT Group and was renamed in 2022. Prior to this transition, he built significant executive leadership experience as a Senior Vice-President and Executive Committee member at GSK Biologicals. His extensive academic background includes an MD specialized in oncology, a PhD from the Ludwig Institute for Cancer Research, and an Executive MBA from Harvard Business School. During his time as a clinical researcher with the FNRS/NFWO, he authored over 90 primary research publications and reviews. Today, he bridges clinical research and investing by supporting companies, organizations, institutions, and individuals focused on immuno-oncology, auto-immunity, and vaccines.
